Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Electromed, Inc. (ELMD)
|
Add to portfolio |
|
|
Price: |
$10.09
| | Metrics |
OS: |
8.56
|
M
| |
|
|
Market cap: |
$86.3
|
M
| |
10
|
% ROIC
|
Net cash:
|
$7.37
|
M
| |
$0.86
|
per share
|
EV:
|
$79
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$4.6
|
M
| |
17.1
|
x EV/EBITDA
|
EBIT
|
$4.0
|
M
| |
19.7
|
x EV/EBIT
|
EPS |
$0.25
| |
40.1
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
Revenues | 48.1 | 41.7 | 35.8 | 32.5 | 31.3 | 28.3 | 25.9 | 23.0 |
Revenue growth | 15.4% | 16.5% | 10.1% | 3.7% | 10.6% | 9.5% | 12.5% | 18.5% |
Cost of goods sold | 11.5 | 10.2 | 8.5 | 7.3 | 7.5 | 6.5 | 5.3 | 5.1 |
Gross profit | 36.5 | 31.4 | 27.3 | 25.2 | 23.8 | 21.8 | 20.6 | 17.9 |
Gross margin | 76.0% | 75.5% | 76.4% | 77.6% | 76.2% | 76.9% | 79.5% | 77.7% |
Selling, general and administrative | 31.6 | 27.1 | 22.4 | 19.9 | 20.4 | 18.8 | 16.4 | 14.4 |
Research and development | 0.9 | 1.4 | 1.7 | 1.0 | 0.6 | 0.3 | 0.6 | 0.4 |
EBITA | 4.1 | 3.1 | 3.1 | 5.2 | 3.0 | 2.8 | 3.7 | 3.2 |
EBITA margin | 8.5% | 7.4% | 8.8% | 16.1% | 9.4% | 10.0% | 14.3% | 14.1% |
Amortization of intangibles | 0.1 | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
EBIT | 4.0 | 3.0 | 3.1 | 5.1 | 2.8 | 2.7 | 3.6 | 3.1 |
EBIT margin | 8.3% | 7.1% | 8.8% | 15.8% | 9.0% | 9.6% | 13.8% | 13.5% |
Pre-tax income | 4.1 | 3.0 | 3.2 | 5.2 | 2.9 | 2.7 | 3.5 | 3.0 |
Income taxes | 0.9 | 0.7 | 0.8 | 1.1 | 0.9 | 0.9 | 1.3 | 0.8 |
Tax rate | 22.5% | 23.1% | 25.4% | 20.6% | 32.2% | 33.0% | 36.7% | 27.3% |
Net income | 3.2 | 2.3 | 0.0 | 4.2 | 2.0 | 1.8 | 2.2 | 2.2 |
Net margin | 6.6% | 5.5% | 0.0% | 12.8% | 6.3% | 6.5% | 8.6% | 9.6% |
|
Diluted EPS | $0.36 | $0.26 | $0.00 | $0.47 | $0.23 | $0.21 | $0.26 | $0.27 |
Shares outstanding (diluted) | 8.7 | 8.8 | 8.9 | 8.8 | 8.6 | 8.6 | 8.5 | 8.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|